· 2026-07-05

Philadelphia Phillies enter Sunday Night Baseball with a 50-39 record, sitting fourth in the National League and riding a one‑game winning streak. Zack Wheeler (6‑1, 2.01 ERA) will start against the Mets, who are listed at +156 odds.
Zack Wheeler, the Phillies' ace, has posted a sub‑2.00 ERA this season and will look to extend his dominance at Citizens Bank Park. Across the mound, David Peterson (3‑5, 5.91 ERA) will try to keep the Mets in the game, but his numbers suggest a tough night against a Phillies staff that has limited opponents to a .240 batting average at home.
The SportsLine model, which has a 22‑10 record on top‑rated picks, lists Philadelphia as a -186 favorite. That means a $186 bet would net $100 if the Phillies win. The over/under is set at eight runs, reflecting the high‑scoring potential of both lineups.
The Phillies bounced back from a 15‑3 loss on Saturday with a 1‑6 win over the Kansas City Royals on July 5, 2026. New York, meanwhile, sits at 34‑42 after taking the series opener on Thursday. Both clubs are looking to solidify their positions in the NL East as the season heads toward the trade deadline.
A victory would push the Phillies to 51‑39, keeping them within striking distance of the division leader. It also reinforces Wheeler's recent surge, giving the bullpen a lighter load in the later innings. For fans, a win on home turf adds momentum heading into the next series against a tough NL opponent.
Key moments will likely hinge on early‑inning run production. Look for Aaron Nola’s bullpen to handle the middle innings, and watch for any late‑inning heroics from Bryce Harper or Nick Castellanos. If the game reaches the over, expect extra‑base hits from both sides, especially with the Mets' power bats still searching for consistency.
The matchup offers a classic NL East showdown, and the odds suggest Philadelphia has the edge. With Wheeler on the hill and the team riding a win streak, the Phillies are poised to capitalize on home‑field advantage and keep their playoff hopes alive.